adults without diabetes more than tripled between 2018 and 2022
The rate of NAION diagnoses was compared across groups to identify potential connections between the medications and eye diagnoses
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Competing interests The authors take full responsibility for the content and conclusions stated in this manuscript
These side effects may result in dehydration, gallbladder issues, hypoglycemia, or, in rare cases, pancreatitis 7
Regulates Appetite Acts on brain receptors that control hunger and satiety, reducing overall appetite and food cravings throughout the day